These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8447687)

  • 1. Exfoliative erythroderma resulting from inadequate intake of branched-chain amino acids in infants with maple syrup urine disease.
    Northrup H; Sigman ES; Hebert AA
    Arch Dermatol; 1993 Mar; 129(3):384-5. PubMed ID: 8447687
    [No Abstract]   [Full Text] [Related]  

  • 2. Acrodermatitis enteropathica-like eruption during treatment of maple syrup urine disease: report of one case.
    Tain YL; Huang SC; Hung FC; Wang HS; Sun PC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):357-60. PubMed ID: 8942030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional deficiency dermatitis related to branched-chain amino acid restriction in a child with maple syrup urine disease.
    Campuzano-García AE; Castanedo-Cázares JP
    Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease.
    Parini R; Sereni LP; Bagozzi DC; Corbetta C; Rabier D; Narcy C; Hubert P; Saudubray JM
    Pediatrics; 1993 Aug; 92(2):280-3. PubMed ID: 8337030
    [No Abstract]   [Full Text] [Related]  

  • 5. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease.
    Berry GT; Heidenreich R; Kaplan P; Levine F; Mazur A; Palmieri MJ; Yudkoff M; Segal S
    N Engl J Med; 1991 Jan; 324(3):175-9. PubMed ID: 1898534
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maple syrup urine disease: report of a mild variant case and results of dietary treatment].
    Stoppoloni G; Santinelli R; Prisco F; Tolone C; D'Ambrosio M
    Pediatria (Napoli); 1978 Sep; 86(3):409-20. PubMed ID: 754161
    [No Abstract]   [Full Text] [Related]  

  • 12. Branched-chain alpha-keto acids for the diagnosis of maple-syrup-urine disease.
    Parsons H; Fung E; Snyder FF
    N Engl J Med; 1987 Apr; 316(15):951. PubMed ID: 3821846
    [No Abstract]   [Full Text] [Related]  

  • 13. A dermatitis secondary to amino-acid deficiency in treated maple syrup urine disease.
    Koch SE; Koch TK; Williams ML
    Arch Pediatr Adolesc Med; 1994 Sep; 148(9):993-4. PubMed ID: 7802785
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatitis in maple syrup urine disease -- a rare and easily overseen complication.
    Baertling F; Mayatepek E; Schlune A; Thimm E; Meißner T
    Klin Padiatr; 2013 Mar; 225(2):88-89. PubMed ID: 23382018
    [No Abstract]   [Full Text] [Related]  

  • 15. Utility of hemodialysis in maple syrup urine disease.
    Puliyanda DP; Harmon WE; Peterschmitt MJ; Irons M; Somers MJ
    Pediatr Nephrol; 2002 Apr; 17(4):239-42. PubMed ID: 11956873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical studies in a patient with maple syrup urine disease (author's transl)].
    Vaca G; Rivas F; Sánchez-Corona J; Olivares N; Aguirre-Negrete MG; González-Quiroga G; Medina C; Hernández A; Cantú JM
    Rev Invest Clin; 1981; 33(4):379-82. PubMed ID: 7330511
    [No Abstract]   [Full Text] [Related]  

  • 17. Ophthalmoplegia and bulbar palsy in variant form of maple syrup urine disease.
    Chhabria S; Tomasi LG; Wong PW
    Ann Neurol; 1979 Jul; 6(1):71-2. PubMed ID: 507761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maple syrup urine disease in Thai infants.
    Pangkanon S; Charoensiriwatana W; Sangtawesin V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemofiltration in acute neonatal metabolic crisis].
    Ring E; Zobel G
    Wien Klin Wochenschr; 1992; 104(21):674-7. PubMed ID: 1475972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment].
    Netter JC; Cossarizza G; Narcy C; Hubert P; Ogier H; Revillon Y; Rabier D; Saudubray JM
    Arch Pediatr; 1994 Aug; 1(8):730-4. PubMed ID: 7842107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.